Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CDC Takes on Prescription Drug Overdose with New Social Media Campaign #RxProblem
  • USA - English


News provided by

Waismann Method

Apr 15, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Waismann Method
Waismann Method
Youtube
Youtube

Los Angeles, California (PRWEB) April 15, 2015 -- Waismann Method® Drug Treatment Center Medical Director congratulates the CDC on new social media initiative to combat prescription drug overdose. Michael H. Lowenstein, M.D., a world-renowned expert on opiate dependence and rapid detoxification, believes that the initiative represents a positive force in combating opiate-related overdose, death, and disability.

We need to engage individuals, their families, and the entire community to combat opiate dependence and encourage those struggling with prescription drug abuse to seek treatment.

Post this

The Waismann Method® Medical Group lauds the Centers for Disease Control and Prevention (CDC) for its new social media initiative to raise awareness of prescription drug abuse in the United States. As international leaders in opiate addiction, detox, and treatment for nearly two decades, Waismann Method® experts are optimistic that the social media campaign will successfully reduce stigma associated with opiate addiction, encourage affected individuals to seek treatment and reduce the epidemic levels of prescription drug abuse, overdose and deaths among across society, including but not limited to: youth, college students and elderly.

Announced at the fourth annual National RX Drug Abuse Summit in Atlanta, the CDC campaign will run through May 15. Entitled “When the Prescription Becomes the Problem,” the social media initiative urges people to write a six-word story or message, create an original video, or post a picture about their experiences with prescription drug abuse. Messages will be posted on Facebook, Instagram, and Twitter using the hashtag #RxProblem. In solidarity with the CDC initiative, the Waismann Method® Medical Group is calling on physicians, mental health professionals, and all those impacted by prescription drug abuse to use the #RxProblem hashtag to share their stories on social media.

“One of the largest barriers to treatment is the misunderstanding and stigma attached to opiate dependence,” said Dr. Michael Lowenstein, Medical Director of the Waismann Method®. “With more than 16,000 people dying from prescription drug overdose in 2013, the CDC social media initiative is an important move in bringing these issues into the public eye. We need to engage individuals, their families, and the entire community to combat opiate dependence and encourage those struggling with prescription drug abuse to seek treatment. This social media campaign is particularly important for reaching our nation’s young people, who are disproportionately affected by drug addiction.”

The Waismann Method Medical® Group pledges to continue combating opiate dependence and encourages the CDC to keep creating innovative solutions to the substance abuse problems facing the nation.

For more information about the Waismann Method®, please visit http://www.opiates.com. For interviews with Dr. Michael H. Lowenstein, please contact Clare Waismann at 310-205-0808 or send an email to info(at)opiates(dot)com.

About Waismann Method Treatment

Since its inception in the late 1990s, the Waismann Method® treatment center has been internationally recognized as a premier facility for opiate treatment. In particular, the facility specializes in rapid opiate detoxification and utilizes state-of-the-art techniques to treat opiate dependence. Located in Southern California, the Waismann Method® treatment center provides comprehensive care for opiate dependence. From anesthesia assisted rapid detoxification to modified medical opiate detoxification, the Waismann Method® medical director ensures that each patient receives individualized care tailored to his or her unique needs. All detoxification treatment is performed in a fully accredited hospital, with aftercare provided in our exclusive Domus Retreat Recovery Center.

Michael H. Lowenstein, M.D., has served as Medical Director for Waismann Method® for nearly 20 years. He is acclaimed as an international authority on opiate addiction and rapid detoxification treatment methods. Dr. Lowenstein holds four board certifications, including board-certification in Addiction Medicine, Pain Management, and Anesthesiology. He has over two decades of experience as a pain specialist and expert in opiate dependence. Most recently, Dr. Lowenstein completed a fellowship and board certification in Anti-Aging, Restorative, and Regenerative Medicine to enhance his understanding of the effects of opioid use on the brain and other body systems. This expertise has been fully integrated into Waismann Method® clinical practice, uses the most advanced methods available to ensure quality of patient experience and outcomes.

Waismann Method® rapid opiate detox is provided in an accredited hospital with specialized services for patients with varying medical and dependency needs. Physicians, therapists, and staff work collaboratively with patients to create a personalized treatment and aftercare plan designed to ensure a healthy and effective transition to a life without opiates. Waismann Method® patients achieve an extraordinarily high success rate, and thousands of patients have been effectively treated using our methods. The professionals at the Waismann Method® treatment center place the utmost importance on compassionate, responsible, patient care.

Find out more about the Waismann Method® at http://www.opiates.com.

Clare Waismann, Waismann Method, http://www.opiates.com, +1 (310) 205-0808, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.